Clinical Trial Update: Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study. [Phase 2, Phase 3]

View source ↗

Summary

Prospective single-center randomized trial comparing terlipressin alone to standard catecholamine therapy for hepatic patients with septic shock (phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Failure
• Liver Disease
• Septic Shock

Drugs mentioned

• Terlipressin (terlipressin)

Snippet

Sponsor: National Hepatology & Tropical Medicine Research Institute | Conditions: Resolution of Septic Shock With Terlipressin | Phase 2, Phase 3 | Status: UNKNOWN